Press Releases

Get the latest on BIO's announcements, positions and views on everything from healthcare to biofuels. 

Featured Press Releases
BIO Statement Regarding Nomination of Robert F…
BIO President & CEO John F. Crowley released the following statement:“A healthy and prosperous society is vitally important to the American people and to the world. The public health, economic security and our national security are best served…
BIO Released the Following Statement After…
“The Biotechnology Innovation Organization (BIO) applauds today's announcement from the USDA's Animal and Plant Health Inspection Service (APHIS) expanding the scope of biotechnology exemptions for modified plants under 7 CFR part 340. This…
BIO Statement on Lawsuit Over 340B Rebates
BIO strongly supports a manufacturer’s ability to use a 340B rebate as an appropriate option to make 340B pricing available to covered entities."Manufacturers should have the choice to effectuate 340B pricing in the manner they deem most efficient…
All Press Releases
  • Show All
Search
Results
Event Tags
May 14, 2019
Today, the Biotechnology Innovation Organization (BIO) released a new report, The State of Innovation in Highly Prevalent Chronic Diseases Volume IV: Alzheimer’s Disease Therapeutics, the fourth in a series on the innovation landscape of highly…
May 8, 2019
Washington, D.C. (May 8, 2019) – The Biotechnology Innovation Organization (BIO) and the National Institutes of Health (NIH) today announced an agreement to feature Small Business Innovation Research (SBIR)-funded early-stage biomedical companies in…
May 7, 2019
Biotechnology Innovation Organization (BIO) President and CEO Jim Greenwood today expressed support for a U.S. House of Representatives letter, authored by Representatives Cindy Axne (D-Iowa) and Adrian Smith (R-Neb.), requesting U.S. Environmental…
April 29, 2019
The Biotechnology Innovation Organization (BIO) today announced that Chairman and CEO of JPMorgan Chase & Co., Jamie Dimon – a leader in the banking industry and catalyst for innovation across American business, including the healthcare industry…
April 29, 2019
The Biotechnology Innovation Organization (BIO) today submitted comments supportive of the U.S. Environmental Protection Agency’s (EPA) “Proposed Rulemaking for Modifications to Fuel Regulations to Provide Flexibility for E15 and to…
April 16, 2019
Washington, D.C. (April 16, 2019) – The Biotechnology Innovation Organization (BIO) announced today the “Right Mix Matters” campaign to increase diversity and inclusion in the biotech industry. Following on its previously announced goals to increase…
April 14, 2019
Biotechnology Innovation Organization (BIO) President and CEO Jim Greenwood today applauded a Senate letter authored by Senator Tina Smith (D-Minn.) and a House letter authored by Representatives Angie Craig (D-Minn.) and Mike Bost (R-Ill.)…
April 3, 2019
Washington, D.C. (April 3, 2019) – The Biotechnology Innovation Organization (BIO) today announced Senator Pat Roberts (R-KS) will be presented with a Lifetime Achievement Award. Senator Roberts will receive the award tonight in conjunction with BIO…
April 3, 2019
As policymakers continue to examine ways to make prescription drugs more affordable, the Biotechnology Innovation Organization (BIO), in conjunction with Morning Consult, has released new polling data that show voters’ views on prescription drug…
March 28, 2019
Pulitzer Prize-winning author, physician and oncologist, Siddhartha Mukherjee with headline BIO 2019 in a keynote speach on Tuesday, June 4.  He is the author of The Emperor of All Maladies: A Biography of Cancer, and the New York…
gooddaybio-cover-final
Daily News You Can’t Afford to Miss

Read it in under 3 minutes!

The Good Day BIO newsletter is the only daily newsletter at the intersection of biotech, politics, and policy.